News
CARDAMYST™ Now Approved Self-Administered Treatment
Advanced Research for Health Improvement played a critical role in research that has resulted in CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
For more information, please read the following announcement from Milestone Pharmacuticals.